Tablette

DRUG2 trials

Sponsors

Medice Arzneimittel Puetter GmbH & Co. KG, Fraunhofer Institute For Translational Medicine And Pharmacology ITMP

Conditions

Adults with ADHD and moderate to severe depressionPatients with ADHD (according to ICD-10 / DSM-5)

Phase 2

Randomized, placebo-controlled clinical trial to investigate the safety and efficacy of two dexamfetamine sulfate formulations in adults with ADHD and moderate to severe depression (DEXAD)

RecruitingCTIS2024-515395-12-00

Fraunhofer Institute For Translational Medicine And Pharmacology ITMPAdults with ADHD and moderate to severe depression

Start: 2025-05-22Target: 105Updated: 2025-11-28

Phase 3

A prospective multi-centric, randomised, double-dummy, double- blind, placebo-controlled 3-way Phase III study to investigate the efficacy and safety of two dexamfetamine sulfate formulations in adults with ADHD - DEXINA -

RecruitingCTIS2022-502903-31-00

Medice Arzneimittel Puetter GmbH & Co. KGPatients with ADHD (according to ICD-10 / DSM-5)

Start: 2025-11-05Target: 380Updated: 2026-01-27